Galactosemia, a single gene disorder with epigenetic consequences.
AuthorsComan, David J
Murray, David W
Byrne, Jennifer C
Rudd, Pauline M
Bagaglia, Paola M
Doran, Peter D
Treacy, Eileen P
AffiliationNational Centre for Inherited Metabolic Disorders, Children's University Hospital, Dublin 1, Ireland.
Chromatography, High Pressure Liquid
Gene Expression Profiling
Oligonucleotide Array Sequence Analysis
Protein Processing, Post-Translational
MetadataShow full item record
CitationGalactosemia, a single gene disorder with epigenetic consequences. 2010, 67 (3):286-92 Pediatr. Res.
AbstractLong-term outcomes of classic galactosemia (GAL) remain disappointing. It is unclear if the complications result mainly from prenatal-neonatal toxicity or persistent glycoprotein and glycolipid synthesis abnormalities. We performed gene expression profiling (T transcriptome) to characterize key-altered genes and gene clusters of four patients with GAL with variable outcomes maintained on a galactose-restricted diet, compared with controls. Significant perturbations of multiple cell signaling pathways were observed including mitogen-activated protein kinase (MAPK) signaling, regulation of the actin cytoskeleton, focal adhesion, and ubiquitin mediated proteolysis. A number of genes significantly altered were further investigated in the GAL cohort including SPARC (osteonectin) and S100A8 (S100 calcium-binding protein). The whole serum N-glycan profile and IgG glycosylation status of 10 treated patients with GAL were compared with healthy control serum and IgG using a quantitative high-throughput analytical HPLC platform. Increased levels of agalactosylated and monogalactosylated structures and decreases in certain digalactosylated structures were identified in the patients. The persistent abnormal glycosylation of serum glycoproteins seen with the microarray data indicates persisting metabolic dyshomeostasis and gene dysregulation in "treated" GAL. Strict restriction of dietary galactose is clearly life saving in the neonatal period; long-term severe galactose restriction may contribute to ongoing systemic abnormalities.
- N-glycan abnormalities in children with galactosemia.
- Authors: Coss KP, Hawkes CP, Adamczyk B, Stöckmann H, Crushell E, Saldova R, Knerr I, Rubio-Gozalbo ME, Monavari AA, Rudd PM, Treacy EP
- Issue date: 2014 Feb 7
- Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
- Authors: Sturiale L, Barone R, Fiumara A, Perez M, Zaffanello M, Sorge G, Pavone L, Tortorelli S, O'Brien JF, Jaeken J, Garozzo D
- Issue date: 2005 Dec
- IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia.
- Authors: Coss KP, Byrne JC, Coman DJ, Adamczyk B, Abrahams JL, Saldova R, Brown AY, Walsh O, Hendroff U, Carolan C, Rudd PM, Treacy EP
- Issue date: 2012 Feb
- N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.
- Authors: Liu Y, Xia B, Gleason TJ, Castañeda U, He M, Berry GT, Fridovich-Keil JL
- Issue date: 2012 Aug
- Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.
- Authors: Maratha A, Stockmann H, Coss KP, Estela Rubio-Gozalbo M, Knerr I, Fitzgibbon M, McVeigh TP, Foley P, Moss C, Colhoun HO, van Erven B, Stephens K, Doran P, Rudd P, Treacy E
- Issue date: 2016 Jul